Healthcare organisations should combine regulatory controls with workflow design, because a diversion programme fails if clinicians work around it. The strongest approach pairs EPCS and PDMP use with processes that are easy to access, simple to follow, and auditable. Leaders should review DEA requirements, test usability in real clinical scenarios, and close gaps that create friction or exceptions.
Designing diversion controls around the clinical workflow
Drug diversion controls work best when they fit how care is actually delivered. In hospitals and clinics, the control is not just the rule, it is the path a nurse, pharmacist, or prescriber must follow under time pressure. If the process adds friction, people will route around it, which weakens both security and auditability.
The practical design question is therefore less about adding more checkpoints and more about making the safe path the easiest path. That usually means aligning policy, dispensing, administration, waste, and reconciliation so the workflow stays clinically usable while still producing defensible evidence.
Where EPCS and PDMP controls help most
NIST SP 800-53 Rev 5 Security and Privacy Controls, CIS Controls v8, and ISO/IEC 27001:2022 Information Security Management all support the same core design principle: access, logging, and review controls need to be implemented in ways that survive daily operations. For diversion programs, EPCS and PDMP checks are strongest when they are integrated into normal medication ordering and review rather than bolted on as a separate compliance ritual.
That matters because EPCS and PDMP use are only protective when they are actually used. If clinicians must leave the flow of care to authenticate again, search another system, or copy information manually, the organisation often gets workarounds, incomplete documentation, or exception handling that erodes the control.
Making diversion controls auditable without creating bottlenecks
CISA Secure by Design is a useful lens here because the control should reduce reliance on user memory and informal discipline. Good diversion design gives staff a clear path for ordering, wasting, witnessing, and reconciling controlled substances, while also preserving a reliable audit trail for reviewers.
Auditable does not have to mean cumbersome. The strongest programs standardise the few actions that create evidentiary value, such as witnessing waste, discrepancy resolution, and exception approval, then make those actions quick to complete and hard to bypass. That keeps the control visible to investigators without making every routine task feel like an investigation.
Risk and Threat Considerations
Drug diversion controls can fail in two ways: clinicians bypass them because they are too hard to use, or bad actors exploit weak workflow points such as waste, overrides, reconciliations, and exception handling. In healthcare, the highest-risk controls are often the ones that create the most friction, because users under pressure look for the fastest path.
Failure mechanism: Inconsistent use of EPCS, PDMP, witnessing, and reconciliation creates gaps that hide unusual ordering or administration patterns, especially when exceptions are handled informally or outside the main workflow.
Impact: The organisation loses both preventive control and investigative visibility, which can lead to undetected diversion, weak evidence for review, and avoidable patient safety and compliance exposure.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | AU-6 — Audit Review, Analysis, and Reporting | Diversion programs depend on reviewable logs and discrepancy analysis. |
| IA-5 — Authenticator Management | EPCS depends on controlled authenticator use and lifecycle management. | |
| AC-6 — Least Privilege | Clinician and pharmacy access should be constrained to the minimum needed. | |
| Recommendation — Review medication events and exception patterns for diversion indicators. Manage EPCS credentials tightly and rotate compromised authenticators quickly. Limit controlled-substance actions to the smallest practical access set. | ||
| CIS Controls v8 | CIS-5 — Account Management | Medication and review workflows rely on well-governed user accounts and access paths. |
| Recommendation — Provision, review, and remove access for medication systems on a strict schedule. | ||
| ISO/IEC 27001:2022 | A.5.15 — Access control | Healthcare diversion controls need access rules that support secure, usable medication workflows. |
| Recommendation — Define and enforce access rules for medication handling systems and records. | ||
Practitioner Guidance
What to verify: Test the control in real clinical scenarios, not just in policy review. If a nurse, pharmacist, or prescriber needs extra logins, duplicate data entry, or manual escalation for routine actions, expect workarounds and false exceptions.
Decision rule: If a control step does not improve either safety or evidence quality, remove the friction or redesign the step. Keep the hard stops for high-risk actions, but make routine compliant behaviour the default rather than the exception.
Practitioner takeaway: A diversion program succeeds when it is operationally boring for compliant users and operationally loud for exceptions; if staff experience the control as a disruption, the control will eventually become a workaround problem.
Related resources from NHI Mgmt Group
- How should healthcare organisations implement single sign-on without disrupting clinical workflows?
- How should healthcare teams reduce password reset tickets without disrupting clinical workflows?
- How should healthcare organisations manage CIS1 to CIS2 migration without disrupting clinical access?
- How should healthcare security teams implement microsegmentation without disrupting clinical workflows?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 26, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
